Male • Age 45-59 • Week 12 Protocol Check: PPI plus escitalopram plus ondansetron, did anyone get Mg or ECG checked?
Cohort check-in for people taking a PPI alongside other common medications. Context: omeprazole inhibits CYP2C19 and, per the escitalopram label, omeprazole 30 mg raised escitalopram AUC by about 50%. Escitalopram and ondansetron can both prolong the QT interval, and low magnesium or potassium raises that risk. Questions: 1) Which PPI and dose are you on (omeprazole 20 mg, pantoprazole 40 mg)? 2) Did your prescriber review your medication list for interactions? 3) Were serum magnesium and potassium checked, and what were the values? 4) Did you have an ECG? 5) Did you get palpitations, dizziness, or cramps? 6) Did switching from omeprazole to pantoprazole, which has less CYP2C19 inhibition, come up? Please share lab values and timing, not dose-change advice.
FDA DailyMed escitalopram labeling reports omeprazole 30 mg increased escitalopram Cmax by about 51% and AUC by about 50%, and notes QT prolongation risk that increases with hypokalemia and hypomagnesemia. Omeprazole labeling also warns about hypomagnesemia with long-term use.